Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Bioinformatics (Oxford, England)
|
October 18, 2019
Patch-DCA: improved protein interface prediction by utilizing structural information and clustering DCA scores
Amir Vajdi, Kourosh Zarringhalam, Nurit Haspel
Msystems
|
December 7, 2021
The Extracellular Milieu of <i>Toxoplasma</i>'s Lytic Cycle Drives Lab Adaptation, Primarily by Transcriptional Reprogramming
Vincent A Primo, Yasaman Rezvani, Andrew Farrell, et al.
JCO Precision Oncology
|
April 23, 2025
Erratum: Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies
Yelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
JCO Precision Oncology
|
March 21, 2025
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies
Yelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
Communications Biology
|
January 18, 2023
The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells
Christopher Noyes, Shunsuke Kitajima, Fengkai Li, et al.
Nature Communications
|
August 25, 2022
Regulation of neuroendocrine plasticity by the RNA-binding protein ZFP36L1
Hsiao-Yun Chen, Yavuz T Durmaz, Yixiang Li, et al.
Cancer Research
|
November 23, 2021
Plasticity in the Absence of NOTCH Uncovers a RUNX2-Dependent Pathway in Small Cell Lung Cancer
Deli Hong, Erik H Knelson, Yixiang Li, et al.
Scientific Reports
|
February 22, 2023
Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment
Peter M Szabo, Amir Vajdi, Namit Kumar, et al.
Cancer Research Communications
|
February 26, 2026
Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results From the Phase 2 LEAP-005 Study
Mariano Ponz-Sarvisé, Sun Young Rha, Carlos A Gomez-Roca, et al.
Nature Medicine
|
August 1, 2025
Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial
Brian I Rini, Elizabeth R Plimack, Viktor Stus, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Bioinformatics (Oxford, England)
|
October 18, 2019
Patch-DCA: improved protein interface prediction by utilizing structural information and clustering DCA scores
Amir Vajdi, Kourosh Zarringhalam, Nurit Haspel
Msystems
|
December 7, 2021
The Extracellular Milieu of <i>Toxoplasma</i>'s Lytic Cycle Drives Lab Adaptation, Primarily by Transcriptional Reprogramming
Vincent A Primo, Yasaman Rezvani, Andrew Farrell, et al.
JCO Precision Oncology
|
April 23, 2025
Erratum: Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies
Yelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
JCO Precision Oncology
|
March 21, 2025
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies
Yelena Y Janjigian, Michael Cecchini, Kohei Shitara, et al.
Communications Biology
|
January 18, 2023
The germline factor DDX4 contributes to the chemoresistance of small cell lung cancer cells
Christopher Noyes, Shunsuke Kitajima, Fengkai Li, et al.
Nature Communications
|
August 25, 2022
Regulation of neuroendocrine plasticity by the RNA-binding protein ZFP36L1
Hsiao-Yun Chen, Yavuz T Durmaz, Yixiang Li, et al.
Cancer Research
|
November 23, 2021
Plasticity in the Absence of NOTCH Uncovers a RUNX2-Dependent Pathway in Small Cell Lung Cancer
Deli Hong, Erik H Knelson, Yixiang Li, et al.
Scientific Reports
|
February 22, 2023
Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment
Peter M Szabo, Amir Vajdi, Namit Kumar, et al.
Cancer Research Communications
|
February 26, 2026
Lenvatinib Plus Pembrolizumab for Patients With Previously Treated Advanced Gastric, Biliary Tract, or Pancreatic Cancer: Results From the Phase 2 LEAP-005 Study
Mariano Ponz-Sarvisé, Sun Young Rha, Carlos A Gomez-Roca, et al.
Nature Medicine
|
August 1, 2025
Pembrolizumab plus axitinib versus sunitinib for advanced clear cell renal cell carcinoma: 5-year survival and biomarker analyses of the phase 3 KEYNOTE-426 trial
Brian I Rini, Elizabeth R Plimack, Viktor Stus, et al.
Page
of 2